BioCentury | Dec 11, 2019
Financial News
Local demand high for Alphamab Oncology’s Hong Kong IPO
...Co. Ltd. (HKEX:2616), CanSino Biologics Inc. (HKEX:6185), Mabpharm Ltd. (HKEX:2181), Shanghai Henlius Biotech Inc. (HKEX:2696), Tot Biopharm Co. Ltd....